Eddie
Let's consider type 1 diabetes with the prevalence of proliferative retinopathy or macular edema. The bars show the proliferative retinopathy. And by 30 years of diabetes about half of the type 1 diabetic patients studied in Wisconsin some years ago had proliferative change. Macular edema is peaking at about 15%. Retinopathy is common. Serious retinopathy is also common.
We move on to consider type 2 diabetes. Type 2 diabetes is somewhat different. The retinopathy plateau here is less, 65%. Why might that be? In the previous example when you saw that the prevalence of serious retinopathy declined with increasing duration, that's not because it's getting better. Unfortunately the people with the complication die. The others are the survivors. But in type 2 diabetes we have a rapid attrition, a high mortality, and the prevalence would actually continue to rise if we were plotting it as a cumulative figure.
To see the full presentation by Professor Roy Taylor, MD, FRCP you need to be a Medscape member. It takes a couple of minutes to sign up, anyone can join and the site has a massive amount of information.
Link to presentation and sign up here.
No comments:
Post a Comment